# Could kisspeptin-10 provoke a vasopressin response?

- Article ID: research-229
- Product: Kisspeptin-10 (kisspeptin-10-677)
- Canonical page: https://heritagebiolabs.com/research-library/articles/229-could-kisspeptin-10-provoke-a-vasopressin-response
- Product collection: https://heritagebiolabs.com/research-library/products/kisspeptin-10
- Product page: https://heritagebiolabs.com/product/kisspeptin-10-677
- Reading focus: Study findings (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2025

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Peptides are short amino-acid chains joined by peptide bonds, and some help the brain coordinate signals across different hormone systems. Kisspeptin-10, or KP-10, is a ten-amino-acid peptide best studied for signaling through the kisspeptin receptor in reproductive physiology. A study published online in November 2025 tested a different question. Would people given a short exposure to KP-10 show a measurable change in vasopressin, a hormone that helps the kidneys conserve water? [1]

The question arose because previous animal studies had reported vasopressin responses to kisspeptin. A reproducible blood response in healthy people might justify testing whether the peptide could help assess the capacity to release vasopressin in people suspected of having a deficiency. In this initial human study, the authors measured vasopressin before and after exposure to kisspeptin 112–121, another name for KP-10, in 12 healthy adults. Six were women and six were men. [1]

The authors found no clear change in circulating vasopressin at the measured times. The men in the small group had higher values overall than the women, but those differences did not amount to a response to the peptide. The investigators looked at the same participants over a short period, so this result speaks most directly to an acute change in circulating vasopressin under the conditions tested. [1]

The study did not enroll people being assessed for vasopressin deficiency, so it could not measure how well a test distinguished people with and without that condition. It also could not determine whether a different pattern of exposure would affect vasopressin or whether signals inside the brain changed without appearing in blood. The authors concluded that their findings gave no support for this particular KP-10 challenge as a diagnostic test. [1]

## Sources

1. Galbiati F et al. Intravenous kisspeptin 112–121 bolus does not acutely impact circulating vasopressin in humans. Journal of Neuroendocrinology (publication 2025-11-22). <https://onlinelibrary.wiley.com/doi/10.1111/jne.70114>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 046 - Kisspeptin-10 and KLOW Blend.docx; article 229; content SHA-256 c8ee9d07e0b1de28afa76e264d0d9242a23c7e9d6790035ea89039afcff30f1a.
